RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Innovative Pharmaceutical Biotech Stock

Innovative Pharmaceutical Biotech Stocks 2024

Innovative Pharmaceutical Biotech Stocks

2.5 B

Ticker

399.HK

ISIN

BMG4783W1073

WKN

A1416X

In 2024, Innovative Pharmaceutical Biotech had 2.5 B outstanding stocks, a 70.64% change from the 1.46 B stocks in the previous year.

The Innovative Pharmaceutical Biotech Stocks history

YEARNUMBER OF STOCKS (undefined HKD)
20242.5
20231.46
20221.46
20211.46
20201.46
20191.46
20181.46
20171.46
20161.41
20151.26
20141.09
20130.78
20120.61
20110.61
20100.52
20090.48
20080.02
20070.02
20060.02
20050.02

Innovative Pharmaceutical Biotech shares outstanding

The number of shares was Innovative Pharmaceutical Biotech in 2023 — This indicates how many shares 1.464 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Innovative Pharmaceutical Biotech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Innovative Pharmaceutical Biotech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Innovative Pharmaceutical Biotech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Innovative Pharmaceutical Biotech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Innovative Pharmaceutical Biotech Aktienanalyse

What does Innovative Pharmaceutical Biotech do?

The company Innovative Pharmaceutical Biotech Ltd is a company that is active in the field of biotechnological and pharmaceutical research and development. The company has its roots in the research and development of innovative active substances and drugs. The company's history began in the 1990s, when a group of scientists came together to bundle their expertise and visions and develop innovative solutions in the field of active substance research. They founded Innovative Pharmaceutical Biotech Ltd as an independent company in 2000. The company's business model is based on the research and development of new active substances and drugs in the field of oncology, neurology, and immunology. The company follows an insistence-driven approach, aiming to develop active substances with innovative mechanisms of action that are superior to proven therapeutic approaches. Innovative Pharmaceutical Biotech Ltd collaborates with a broad network of partners and cooperation partners, including academic research institutions, clinical centers, biotech companies, and pharmaceutical companies. The company cooperates with companies from all over the world and operates worldwide. The company has various divisions, each focusing on the development of active substances and drugs in specific medical fields. In the oncology division, the company develops active substances and drugs for the treatment of cancer. In the neurology division, active substances and drugs for the treatment of neurological diseases such as Alzheimer's and Parkinson's are researched and developed. The immunology division of the company is dedicated to the development of active substances and drugs for the treatment of immune system diseases such as autoimmune diseases and inflammations. Over the years, the company has developed and launched a number of products. One of its most important products is an active substance for the treatment of breast cancer, which has shown promising results in clinical studies. The company has also developed a treatment for the relief of pain in cancer and other patients based on chemotherapy symptoms. In addition to its research and development efforts, Innovative Pharmaceutical Biotech Ltd attaches great importance to compliance with standards and regulations in the pharmaceutical and biotechnological industry. The company maintains strict quality control procedures and strives to adhere to the highest standards in drug manufacturing. Innovative Pharmaceutical Biotech Ltd sees itself as a pioneer in the pharmaceutical and biotechnological industry and takes pride in developing innovative solutions that have the potential to improve the lives of people around the world. The company has a variety of partners and cooperation partners worldwide and is proud to have a global presence in the field of biotechnological and pharmaceutical research and development. In summary, Innovative Pharmaceutical Biotech Ltd is a company that focuses on the research and development of innovative active substances and drugs that have the potential to improve the lives of people worldwide. The company collaborates with a broad network of partners and cooperation partners and maintains strict quality control procedures to adhere to the highest standards in drug manufacturing. The translation is as accurate as possible. Innovative Pharmaceutical Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Innovative Pharmaceutical Biotech's Shares Outstanding

Innovative Pharmaceutical Biotech's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Innovative Pharmaceutical Biotech’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Innovative Pharmaceutical Biotech’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Innovative Pharmaceutical Biotech’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Innovative Pharmaceutical Biotech stock

How many stocks are there of Innovative Pharmaceutical Biotech?

The current number of stocks of Innovative Pharmaceutical Biotech is 2.5 B undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Innovative Pharmaceutical Biotech are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Innovative Pharmaceutical Biotech evolved in recent years?

The number of shares of Innovative Pharmaceutical Biotech has increased by 70.64% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Innovative Pharmaceutical Biotech as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Innovative Pharmaceutical Biotech?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Innovative Pharmaceutical Biotech pay?

Over the past 12 months, Innovative Pharmaceutical Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovative Pharmaceutical Biotech is expected to pay a dividend of 0 HKD.

What is the dividend yield of Innovative Pharmaceutical Biotech?

The current dividend yield of Innovative Pharmaceutical Biotech is .

When does Innovative Pharmaceutical Biotech pay dividends?

Innovative Pharmaceutical Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innovative Pharmaceutical Biotech?

Innovative Pharmaceutical Biotech paid dividends every year for the past 0 years.

What is the dividend of Innovative Pharmaceutical Biotech?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innovative Pharmaceutical Biotech located?

Innovative Pharmaceutical Biotech is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Innovative Pharmaceutical Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innovative Pharmaceutical Biotech from 12/31/2003 amounting to 0.02 HKD, you needed to have the stock in your portfolio before the ex-date on 12/10/2003.

When did Innovative Pharmaceutical Biotech pay the last dividend?

The last dividend was paid out on 12/31/2003.

What was the dividend of Innovative Pharmaceutical Biotech in the year 2023?

In the year 2023, Innovative Pharmaceutical Biotech distributed 0 HKD as dividends.

In which currency does Innovative Pharmaceutical Biotech pay out the dividend?

The dividends of Innovative Pharmaceutical Biotech are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Innovative Pharmaceutical Biotech

Our stock analysis for Innovative Pharmaceutical Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovative Pharmaceutical Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.